# Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS

> **NCT01477970** · — · COMPLETED · sponsor: **Iakentro Fertility Centre** · enrollment: 38 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01477970
- **Lead sponsor:** Iakentro Fertility Centre
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2011-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01477970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01477970, "Double GnRH Antagonist Daily Dose in Hyperresponding IVF/ICSI Cycles May Prevent the OHSS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01477970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*